150 related articles for article (PubMed ID: 2478766)
1. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers.
Hiremath AN; Hoffman BB; Blaschke TF
J Cardiovasc Pharmacol; 1989 Oct; 14(4):534-41. PubMed ID: 2478766
[TBL] [Abstract][Full Text] [Related]
2. Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenoceptors and ion channels.
Bauer JA; Fung HL; Zheng W; Kwon YW; Gopalakrishnan M; Triggle DJ
J Cardiovasc Pharmacol; 1993 Oct; 22(4):600-8. PubMed ID: 7505363
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
[TBL] [Abstract][Full Text] [Related]
4. Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance.
Milone SD; Pace-Asciak CR; Reynaud D; Azevedo ER; Newton GE; Parker JD
J Cardiovasc Pharmacol; 1999 May; 33(5):685-90. PubMed ID: 10226853
[TBL] [Abstract][Full Text] [Related]
5. Transdermal nitroglycerin in angina pectoris.
Abrams J
Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
[TBL] [Abstract][Full Text] [Related]
6. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
[TBL] [Abstract][Full Text] [Related]
7. Ointments and transdermal nitroglycerin patches for stable angina pectoris.
Thadani U; Lipicky RJ
Cardiovasc Drugs Ther; 1994 Aug; 8(4):625-33. PubMed ID: 7848897
[TBL] [Abstract][Full Text] [Related]
8. Antianginal effects of nitroglycerin patches.
Reichek N; Priest C; Zimrin D; Chandler T; Sutton MS
Am J Cardiol; 1984 Jul; 54(1):1-7. PubMed ID: 6430053
[TBL] [Abstract][Full Text] [Related]
9. Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C.
Zierhut W; Ball HA
Br J Pharmacol; 1996 Sep; 119(1):3-5. PubMed ID: 8872349
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
[TBL] [Abstract][Full Text] [Related]
11. Regional and systemic hemodynamic and humoral effects of transdermal nitroglycerin in mild hypertension.
Pedrinelli R; Graziadei L; Panarace G; Duranti P; Motolese M; Salvetti A
J Cardiovasc Pharmacol; 1989 Oct; 14(4):636-41. PubMed ID: 2478778
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.
Flaherty JT
Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161
[TBL] [Abstract][Full Text] [Related]
13. [The noninvasive quantitative evaluation of the acute hemodynamic effects of sublingual and transdermal nitroglycerin in man].
Pizzetti F; Peci P; Manni B; Bonaglia M; Ghio S; Latini R; Avanzini F
G Ital Cardiol; 1993 Apr; 23(4):327-34. PubMed ID: 8319860
[TBL] [Abstract][Full Text] [Related]
14. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance.
Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H
Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267
[TBL] [Abstract][Full Text] [Related]
15. Nitroglycerin-induced relaxation of anorectal smooth muscle: evidence for apparent lack of tolerance development in the anaesthetized rat.
Wang EQ; Soda DM; Fung HL
Br J Pharmacol; 2001 Sep; 134(2):418-24. PubMed ID: 11564661
[TBL] [Abstract][Full Text] [Related]
16. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Probes with inhibitors and tolerance development.
Chung SJ; Fung HL
Biochem Pharmacol; 1993 Jan; 45(1):157-63. PubMed ID: 8424809
[TBL] [Abstract][Full Text] [Related]
17. Nitroglycerin in chronic stable angina pectoris.
Reichek N
Am J Cardiol; 1987 Nov; 60(15):15H-17H. PubMed ID: 3120561
[TBL] [Abstract][Full Text] [Related]
18. Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.
Todd PA; Goa KL; Langtry HD
Drugs; 1990 Dec; 40(6):880-902. PubMed ID: 2127741
[TBL] [Abstract][Full Text] [Related]
19. Rapid development of nitrate tolerance in healthy volunteers: assessment using spectral analysis of short-term blood pressure and heart rate variability.
Cloarec-Blanchard L; Funck-Brentano C; Carayon A; Jaillon P
J Cardiovasc Pharmacol; 1994 Aug; 24(2):266-73. PubMed ID: 7526059
[TBL] [Abstract][Full Text] [Related]
20. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance.
Hill M; Takano H; Tang XL; Kodani E; Shirk G; Bolli R
Circulation; 2001 Aug; 104(6):694-9. PubMed ID: 11489777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
